CAPTEM (capecitabine and temozolomide) provided a high rate of disease control in patients with typical and atypical lung ...
Preliminary analysis of one-year progression-free survival data from Phase 2 study of novel SST2 agonist paltusotine under ...
Pharmaceuticals announced three abstracts from its clinical development programs will be presented at the upcoming North American ...
Exelixis, Inc. (Nasdaq: EXEL) today announced results from a subgroup analysis of the CABINET phase 3 pivotal trial evaluating CABOMETYX® (cabozantinib) versus placebo in patients with previously ...
Hosted on MSN
Everything You Need to Know About Lung Cancer
Lung cancer is cancer that starts in your lungs. It is the leading cause of cancer death among men and women. Finding lung cancer early before it spreads improves your chances of beating the disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback